| Medical Industry Group |
 |
 |
 |
|
The NVCA formed its Medical Industry Group to better address the unique needs of its members that invest in the life sciences. The focus of the group is to advocate for issues important to venture capitalists who invest in lifescience companies, conduct outreach to other industry and patient organizations and to collect and disseminate information about venture investment in the lifesciences sector. Venture investing in the life sciences (biotechnology, medical devices, and health care services) represent approximately 30% of all venture investment. Venture backed life science companies are responsible for the majority of new, innovative therapies, devices and services that are revolutionizing the health care industry and greatly improving the standard of living for people around the world. The primary goal of the Medical Industry Group is to highlight the importance of venture capital in life sciences innovation to policy makers, regulators and the general public. Click here to download Patient Capital, a study that illustrates the crucial role VCs play in bringing innovative therapies, devices and procedures to the patient. For more information about NVCA's Medical Industry Group contact Kelly Slone at This e-mail address is being protected from spambots. You need JavaScript enabled to view it . |